Trial Profile
A Blinded, Placebo- and Comparator-Controlled Three-way Crossover Study to Investigate the Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of JNJ-40411813 in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Oct 2013
Price :
$35
*
At a glance
- Drugs ADX 71149 (Primary) ; Citalopram
- Indications Anxiety disorders; Major depressive disorder; Psychiatric disorders; Schizophrenia
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Janssen Research & Development
- 05 Oct 2013 New trial record